# Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery

> **NCT00320619** · NA · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 182 (actual)

## Conditions studied

- Scoliosis
- Kyphosis
- Lordosis
- Spondylitis
- Spinal Stenosis

## Interventions

- **DRUG:** Epsilon-Aminocaproic Acid (EACA)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00320619
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2016-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00320619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00320619, "Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00320619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*